Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1957 2
1960 1
1965 1
1966 2
1968 1
1969 1
1970 1
1971 3
1973 1
1974 2
1975 4
1976 83
1977 128
1978 111
1979 152
1980 417
1981 859
1982 909
1983 804
1984 841
1985 764
1986 1070
1987 843
1988 1081
1989 1220
1990 1522
1991 1416
1992 1631
1993 1647
1994 1684
1995 1732
1996 1773
1997 1849
1998 1988
1999 2080
2000 2129
2001 2103
2002 2390
2003 2599
2004 2831
2005 3360
2006 3838
2007 4305
2008 4904
2009 5113
2010 5705
2011 6574
2012 6760
2013 7150
2014 7501
2015 7487
2016 7330
2017 6991
2018 7293
2019 7474
2020 7998
2021 8553
2022 7879
2023 7612
2024 6493
2025 1847

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149,512 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Safwatun
Page 1
Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.
Kibaly C, Alderete JA, Liu SH, Nasef HS, Law PY, Evans CJ, Cahill CM. Kibaly C, et al. Cell Mol Neurobiol. 2021 Jul;41(5):899-926. doi: 10.1007/s10571-020-01013-y. Epub 2020 Nov 27. Cell Mol Neurobiol. 2021. PMID: 33245509 Free PMC article. Review.
It is estimated that nearly a third of people who abuse drugs started with prescription opioid medicines. Approximately, 11.5 million Americans used prescription drugs recreationally in 2016, and in 2018, 46,802 Americans died as the result of an opioid overdose, including …
It is estimated that nearly a third of people who abuse drugs started with prescription opioid medicines. Approximately, 11.5 million …
The NIDA Avenir award in genetics or epigenetics of substance use disorders.
Satterlee JS, Pollock JD, Volkow ND. Satterlee JS, et al. Mol Cell Neurosci. 2023 Dec;127:103899. doi: 10.1016/j.mcn.2023.103899. Epub 2023 Sep 20. Mol Cell Neurosci. 2023. PMID: 37739148 Review.
NIDA's Avenir Program in the Genetics or Epigenetics of Substance Use Disorders (SUDs) was launched to support early stage investigators who propose innovative, high risk, but potentially high impact research and who show promise of being tomorrow's leaders in this scienti …
NIDA's Avenir Program in the Genetics or Epigenetics of Substance Use Disorders (SUDs) was launched to support early stage investigat …
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic.
Tai B, Dobbins R, Blackeney Q, Liu D, Moran L. Tai B, et al. Addict Sci Clin Pract. 2021 May 8;16(1):28. doi: 10.1186/s13722-021-00238-6. Addict Sci Clin Pract. 2021. PMID: 33964973 Free PMC article.
Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a nationwide conso …
Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the Nationa …
National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings.
Perrone J, Haroz R, D'Orazio J, Gianotti G, Love J, Salzman M, Lowenstein M, Thakrar A, Klipp S, Rae L, Reed MK, Sisco E, Wightman R, Nelson LS. Perrone J, et al. Ann Emerg Med. 2024 Jul;84(1):20-28. doi: 10.1016/j.annemergmed.2024.01.041. Epub 2024 Mar 16. Ann Emerg Med. 2024. PMID: 38493376 Free PMC article. Review.
This report reflects the Proceedings of the National Institute on Drug Abuse Center for the Clinical Trials Network convening of clinical and scientific experts, federal staff, and other stakeholders to describe emerging best practices for treating peo …
This report reflects the Proceedings of the National Institute on Drug Abuse Center for the Clinical Trials Netw …
Harm reduction.
Normand J, Li JH, Thomson N, Jarlais DD. Normand J, et al. J Food Drug Anal. 2013 Oct;21(4):S10-S12. doi: 10.1016/j.jfda.2013.09.022. J Food Drug Anal. 2013. PMID: 25278732 Free PMC article.
Jacques Normand, Director of the AIDS Research Program of the U.S. National Institute on Drug Abuse. The three presenters (and their presentation topics) were: Dr. ...
Jacques Normand, Director of the AIDS Research Program of the U.S. National Institute on Drug Abuse …
Are we compulsively chasing rainbows?
George O, Ahmed SH, Gilpin NW. George O, et al. Neuropsychopharmacology. 2022 Nov;47(12):2013-2015. doi: 10.1038/s41386-022-01419-w. Epub 2022 Aug 18. Neuropsychopharmacology. 2022. PMID: 35982236 Free PMC article. Review. No abstract available.
A mapping review of NIDA-funded implementation research studies on treatments for opioid and/or stimulant use disorders.
Cheng H, Chokron Garneau H, Yuan M, McGovern MP. Cheng H, et al. Drug Alcohol Depend. 2021 Aug 1;225:108767. doi: 10.1016/j.drugalcdep.2021.108767. Epub 2021 May 21. Drug Alcohol Depend. 2021. PMID: 34052689 Free PMC article. Review.
This study assessed how implementation research has been deployed in the National Institute on Drug Abuse (NIDA) efforts to address the opioid and stimulant epidemics. ...RESULTS: An initial search across NIH institutes yielded 5963 relevant rec …
This study assessed how implementation research has been deployed in the National Institute on Drug Abuse (NI …
Needle Insertion Difficulty Algorithm (NIDA): A novel pilot study to predict Huber needle insertion difficulty in totally implanted devices.
Civetta G, Lombardi L, Lanotte A, Delvecchio AM, Colonnata M, Todisco A, Cristallo R, Marcone A, Somma M, Vitale E, Giammarinaro MP, Bruno G, Caldarola GG. Civetta G, et al. J Vasc Access. 2023 May;24(3):492-496. doi: 10.1177/11297298211040343. Epub 2021 Aug 18. J Vasc Access. 2023. PMID: 34405754 Review.

In particular, the type of implanted port, that is, if it was a brachial or thoracic implant (p < 0.001), the SPIA type, if type 1, 2, or 3 (p < 0.001) and the experience of the clinician (p < 0.001) were considered as predictors of a successful first attempt and then ca

…

In particular, the type of implanted port, that is, if it was a brachial or thoracic implant (p < 0.001), the SPIA type, if type 1, 2, or

…
149,512 results
You have reached the last available page of results. Please see the User Guide for more information.